BR

Bridget Riley‐Gillis

AbbVie (United States) US

ORCID 0000-0001-7338-1156
91
Publications
10,918
Citations
29
H-Index
42
i10-Index
8.0
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Research Topics

Protein Degradation and Inhibitors (24) Multiple Myeloma Research and Treatments (14) Genetic Associations and Epidemiology (11) CAR-T cell therapy research (10) PARP inhibition in cancer therapy (10)

Affiliations

University of Iowa
US 2007 - 2007
Merck & Co., Inc., Rahway, NJ, USA (United States)
US 2021 - 2020
Biogen (United States)
US 2021 - 2021
University of Helsinki
FI 2023 - 2020
Janssen (Belgium)
BE 2022 - 2022

Share Profile

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now